Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

2articles mentioning drugs

8drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: Atez/Bev ×

Atez/Bev

This drug is selected. Its supporting articles are shown below.

Articles mentioning Atez/Bev

2 articles · page 1 of 1

Carbonic anhydrase 9 as a circulating biomarker and therapeutic target in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab

jitc · abstract · 2026-04-09 · 5 matching annotations

92.9%

Atezolizumab Atez/Bev bevacizumab HCC hepatocellular carcinoma

…Background Atezolizumab plus bevacizumab (Atez/Bev) has become the first-line therapy f…

Systemic immune profiling uncovers divergent mechanisms and predictive biomarkers of response to combination immunotherapies in hepatocellular carcinoma

jitc · abstract · 2026-03-30 · 3 matching annotations

82.4%

atezolizumab durvalumab tremelimumab Dur/Tre bevacizumab Atez/Bev Atez/Bev HCC

…Background Combination immunotherapies such as atezolizumab plus bevacizumab (Atez/Bev) and durvalumab plus tremelimumab (D…